269 related articles for article (PubMed ID: 19706538)
1. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.
Grgic I; Kiss E; Kaistha BP; Busch C; Kloss M; Sautter J; Müller A; Kaistha A; Schmidt C; Raman G; Wulff H; Strutz F; Gröne HJ; Köhler R; Hoyer J
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14518-23. PubMed ID: 19706538
[TBL] [Abstract][Full Text] [Related]
2. Potassium channels: the 'master switch' of renal fibrosis?
Menè P; Pirozzi N
Nephrol Dial Transplant; 2010 Feb; 25(2):353-5. PubMed ID: 19945954
[TBL] [Abstract][Full Text] [Related]
3. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
[TBL] [Abstract][Full Text] [Related]
4. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
7. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
8. Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis.
Anumanthan G; Wilson PJ; Tripathi R; Hesemann NP; Mohan RR
Exp Eye Res; 2018 Feb; 167():140-144. PubMed ID: 29242028
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II upregulates K(Ca)3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts.
Wang LP; Wang Y; Zhao LM; Li GR; Deng XL
Biochem Pharmacol; 2013 May; 85(10):1486-94. PubMed ID: 23500546
[TBL] [Abstract][Full Text] [Related]
10. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
[TBL] [Abstract][Full Text] [Related]
11. Altered K
Seo CH; Cui HS; Kim JB
Transl Res; 2021 Oct; 236():133-146. PubMed ID: 33905948
[TBL] [Abstract][Full Text] [Related]
12. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM
Diabetes; 2013 Aug; 62(8):2923-34. PubMed ID: 23656889
[TBL] [Abstract][Full Text] [Related]
13. Renal Fibrosis, Immune Cell Infiltration and Changes of TRPC Channel Expression after Unilateral Ureteral Obstruction in Trpc6-/- Mice.
Kong W; Haschler TN; Nürnberg B; Krämer S; Gollasch M; Markó L
Cell Physiol Biochem; 2019; 52(6):1484-1502. PubMed ID: 31099508
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.
Xiong C; Masucci MV; Zhou X; Liu N; Zang X; Tolbert E; Zhao TC; Zhuang S
Oncotarget; 2016 Oct; 7(43):69291-69308. PubMed ID: 27732564
[TBL] [Abstract][Full Text] [Related]
15. Impact of AMP-Activated Protein Kinase α1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction.
Mia S; Federico G; Feger M; Pakladok T; Meissner A; Voelkl J; Groene HJ; Alesutan I; Lang F
PLoS One; 2015; 10(8):e0135235. PubMed ID: 26285014
[TBL] [Abstract][Full Text] [Related]
16. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.
Zhang B; Liu P; Zhou Y; Chen Z; He Y; Mo M; Dai G; Xia W; Du Y; Liu Y; Chen X
Life Sci; 2019 Apr; 223():29-37. PubMed ID: 30862567
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction.
Baba I; Egi Y; Utsumi H; Kakimoto T; Suzuki K
Mol Med Rep; 2015 Dec; 12(6):8010-20. PubMed ID: 26498136
[TBL] [Abstract][Full Text] [Related]
20. The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosis.
Roach KM; Duffy SM; Coward W; Feghali-Bostwick C; Wulff H; Bradding P
PLoS One; 2013; 8(12):e85244. PubMed ID: 24392001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]